VRCA Q1 2022 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

VRCAVerrica Pharmaceuticals Inc.

$56M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$431,000-96.4% YoY

Gross Profit

$153,00035.5% margin

Operating Income

-$7M-1719.3% margin

Net Income

-$8M-1965.2% margin

EPS (Diluted)

$-3.08

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$72M

Total Liabilities

$46M

Stockholders' Equity

$25M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$431,000	$12M	-96.4%
Gross Profit	$153,000	$12M	-98.7%
Operating Income	-$7M	$60,000	-12450.0%
Net Income	-$8M	-$936,000	-804.9%